Alerus Investment Advisors’s Mondelez International MDLZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$1.59M Sell
39,669
-34,470
-46% -$1.4M 0.28% 81
2015
Q4
$3.32M Sell
74,139
-507
-0.7% -$22.7K 0.55% 56
2015
Q3
$3.13M Sell
74,646
-59,883
-45% -$2.58M 0.55% 57
2015
Q2
$4.86M Sell
134,529
-186
-0.1% -$7.29K 0.81% 37
2015
Q1
$4.85M Buy
134,715
+23,438
+21% +$847K 0.81% 37
2014
Q4
$4.04M Sell
111,277
-4,757
-4% -$173K 0.68% 49
2014
Q3
$3.98M Buy
116,034
+10,274
+10% +$374K 0.69% 49
2014
Q2
$3.98M Buy
105,760
+976
+0.9% +$35.7K 0.69% 42
2014
Q1
$3.62M Sell
104,784
-6,033
-5% -$206K 0.78% 49
2013
Q4
$3.91M Sell
110,817
-107,553
-49% -$3.57M 0.86% 51
2013
Q3
$6.86M Buy
218,370
+21,184
+11% +$657K 1.37% 23
2013
Q2
$5.63M Buy
+197,186
New +$6M 0.87% 43

Other funds holding MDLZ

Alerus Investment Advisors's MDLZ Position: Q1 2016 in Review

Alerus Investment Advisors reduced its Mondelez International (MDLZ) stake by 46% in Q1 2016, selling an estimated $1.4M and leaving 39,669 shares worth $1.59M. The position accounts for 0.28% of the portfolio, ranked #81.

Alerus Investment Advisors first reported a position in MDLZ in Q2 2013 and has held it in 12 quarters since. The position peaked at $6.86M in Q3 2013. 1,207 funds tracked by Wall St. Rank hold MDLZ as of Q1 2016.

  • Alerus Investment Advisors held 39,669 shares of Mondelez International worth $1.59M as of Q1 2016.
  • Alerus Investment Advisors sold 34,470 Mondelez International shares in Q1 2016, an estimated $1.4M.
  • Mondelez International made up 0.28% of Alerus Investment Advisors's portfolio in Q1 2016, its #81 holding.
  • Alerus Investment Advisors first reported a position in Mondelez International in Q2 2013 and has held it in 12 quarters since.
  • Alerus Investment Advisors's Mondelez International position peaked at $6.86M in Q3 2013.
  • 1,207 funds tracked by Wall St. Rank held Mondelez International as of Q1 2016.

Based on Alerus Investment Advisors's 13F filing for Q1 2016, filed 4 May 2016.